IN2014CN03414A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03414A
IN2014CN03414A IN3414CHN2014A IN2014CN03414A IN 2014CN03414 A IN2014CN03414 A IN 2014CN03414A IN 3414CHN2014 A IN3414CHN2014 A IN 3414CHN2014A IN 2014CN03414 A IN2014CN03414 A IN 2014CN03414A
Authority
IN
India
Prior art keywords
gene cluster
genes comprised
methylgriselimycin
griselimycin
biosynthesis
Prior art date
Application number
Other languages
English (en)
Inventor
Mark Broenstrup
Caudia Koenig
Luigi Toti
Joachim Wink
Wulf Leuschner
Johann Gassenhuber
Rolf Mueller
Silke Wenzel
Tina Binz
Carsten Volz
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11306400.0A external-priority patent/EP2586791A1/de
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IN2014CN03414A publication Critical patent/IN2014CN03414A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/24—Proline; Hydroxyproline; Histidine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
IN3414CHN2014 2011-10-12 2012-10-11 IN2014CN03414A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11306321 2011-10-12
EP11306400.0A EP2586791A1 (de) 2011-10-28 2011-10-28 Gencluster zur Biosynthese von Griselimycin und Methylgriselimycin
PCT/EP2012/070213 WO2013053857A2 (en) 2011-10-12 2012-10-11 Gene cluster for biosynthesis of griselimycin and methylgriselimycin

Publications (1)

Publication Number Publication Date
IN2014CN03414A true IN2014CN03414A (de) 2015-10-09

Family

ID=47559376

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3414CHN2014 IN2014CN03414A (de) 2011-10-12 2012-10-11

Country Status (7)

Country Link
US (1) US9422566B2 (de)
EP (1) EP2766389B1 (de)
JP (1) JP6430250B2 (de)
CN (1) CN104024272B (de)
EA (1) EA029209B1 (de)
IN (1) IN2014CN03414A (de)
WO (1) WO2013053857A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014CN03414A (de) 2011-10-12 2015-10-09 Sanofi Sa
US10336999B2 (en) 2015-05-29 2019-07-02 Zymergen Inc. Compositions and methods for activating silent gene clusters
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
WO2017100376A2 (en) 2015-12-07 2017-06-15 Zymergen, Inc. Promoters from corynebacterium glutamicum
KR102345899B1 (ko) 2016-06-30 2021-12-31 지머젠 인코포레이티드 박테리아 헤모글로빈 라이브러리를 생성하는 방법 및 이의 용도
WO2018005793A1 (en) 2016-06-30 2018-01-04 Zymergen Inc. Methods for generating a glucose permease library and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2126108B1 (de) 1971-02-25 1974-08-02 Rhone Poulenc Sa
FI107053B (fi) 1998-10-23 2001-05-31 Galilaeus Oy Nogalamysiinin biosynteesiin liittyvä geeniryhmittymä ja sen käyttö hybridiantibioottien tuotossa
JP2004510449A (ja) * 2000-10-13 2004-04-08 エコピア　バイオサイエンス　インク ラモプラニン生合成用遺伝子クラスター
KR20040032891A (ko) * 2001-08-06 2004-04-17 큐비스트 파마슈티컬즈 인코포레이티드 답토마이신 생합성 유전자 클러스터에 관련된 조성물 및방법
CN1388252A (zh) * 2002-08-06 2003-01-01 中国医学科学院医药生物技术研究所 吸水链霉菌17997生物合成格尔德霉素的基因簇
CN102021187A (zh) * 2003-10-23 2011-04-20 上海交通大学 Fr-008聚酮抗生素生物合成相关的基因簇
CN101016533B (zh) * 2005-11-09 2010-05-19 上海医药工业研究院 一种蒽环类抗生素产生工程菌及其应用
US8609367B2 (en) * 2007-08-03 2013-12-17 Sentinella Pharmaceuticals, Inc. Genes and proteins for the biosynthesis of the lantibiotic 107891
CN101586112B (zh) * 2009-06-19 2011-06-22 中国科学院上海有机化学研究所 诺丝七肽的生物合成基因簇
IN2014CN03414A (de) 2011-10-12 2015-10-09 Sanofi Sa

Also Published As

Publication number Publication date
EP2766389B1 (de) 2017-03-29
JP6430250B2 (ja) 2018-11-28
US9422566B2 (en) 2016-08-23
EA201490767A1 (ru) 2014-09-30
EP2766389A2 (de) 2014-08-20
WO2013053857A2 (en) 2013-04-18
JP2014530609A (ja) 2014-11-20
WO2013053857A3 (en) 2013-08-01
US20140295457A1 (en) 2014-10-02
CN104024272A (zh) 2014-09-03
CN104024272B (zh) 2018-04-20
EA029209B1 (ru) 2018-02-28

Similar Documents

Publication Publication Date Title
PH12019502292A1 (en) Methods and compositions for treatment of a genetic condition
AU2011356210A8 (en) Novel fucosyltransferases and their applications
HK1207111A1 (en) Methods and compositions for controlling gene expression by rna processing rna
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
IN2014CN03414A (de)
MX2018013216A (es) Composiciones y metodos para inhibir la expresion del gen de proteasa transmembrana, serina 6 (tmprss6).
WO2013060867A3 (en) Production of heterodimeric proteins
IN2014DN08812A (de)
MX349630B (es) Alfa-amilasas.
EP3698631A3 (de) Verfahren zur abgabe von oligonukleotiden an immunzellen
MX356625B (es) Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva.
IN2014DN08481A (de)
WO2013012921A3 (en) Nucleic acid aptamers
MX2014004598A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
EP4253534A3 (de) Alpha-amylase-varianten und polynukleotide zur codierung davon
MY182946A (en) Production of organic acids by fermentation at low ph
MY167208A (en) Partially Hydrolyzed Casein-Whey Nutritional Compositions for Reducing the Onset of Allergies
FI20115328A0 (fi) Uusia kutinaaseja, niiden tuottaminen ja käytöt
IN2014DN03298A (de)
ZA201307315B (en) Gene cluster for biosynthesis of cycloclavine
EP2922954A4 (de) Gencluster zur biosynthese von cornexistin und hydroxycornexistin
IN2014DN05672A (de)
MX2016008716A (es) Expresion aumentada de proteinas.
MX2016008595A (es) Expresion mejorada de proteínas.
UA64452U (ru) Применение гена аполипопротеида Е (апоЕ) в качестве средства для профилактики кардиосклероза